UVISPI Trademark

Trademark Overview

On Monday, December 12, 2022, a trademark application was filed for UVISPI with the United States Patent and Trademark Office. The USPTO has given the UVISPI trademark a serial number of 97713281. The federal status of this trademark filing is ABANDONED - EXPRESS as of Friday, December 16, 2022. This trademark is owned by Glaxo Group Limited. The UVISPI trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
uvispi

General Information

Serial Number97713281
Word MarkUVISPI
Filing DateMonday, December 12, 2022
Status601 - ABANDONED - EXPRESS
Status DateFriday, December 16, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Friday, December 16, 2022ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Friday, December 16, 2022ABANDONMENT - EXPRESS MAILED
Thursday, December 15, 2022TEAS EXPRESS ABANDONMENT RECEIVED
Thursday, December 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 15, 2022NEW APPLICATION ENTERED IN TRAM

Related Keywords

uvispi treatment preparations pharmaceutical diseases disorders hepatological respiratory oncological genitourinary cardiovascular